Clinical Trials
23 trialsNCT07547163 2026-04-23
LGG PRO's
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Recruiting
NCT04075305 2026-03-05
MOMENTUM
UMC Utrecht
Recruiting
NCT05925218 2026-03-05
m-ctDNA
University Health Network, Toronto
Active not recruiting
NCT07448493 2026-03-04
GASTROBRAIN
Blokhin's Russian Cancer Research Center
Active not recruiting
NCT07448662 2026-03-04
COLBRAIN
Blokhin's Russian Cancer Research Center
Active not recruiting
NCT06528912 2024-07-30
Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)
University Medical Center Groningen
Recruiting
NCT06102837 2023-10-26
Tumor Vaccines for Solid Tumors
Huashan Hospital
Recruiting
NCT05982691 2023-08-08
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
National Cancer Center, Korea
Recruiting
NCT05616377 2022-11-15
CLTBME
Sun Yat-sen University
Unknown
NCT03394716 2021-04-19
Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors
The Netherlands Cancer Institute
Terminated
NCT02974127 2021-02-21
MuRaLM
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Unknown
NCT04735939 2021-02-03
Chronotherapy for Radiotherapy of Glioma
General Hospital of Ningxia Medical University
Unknown
NCT02213536 2019-02-22
SPARE
HCA International Limited
Terminated
NCT00471653 2018-07-09
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Terminated
NCT02329795 2017-10-12
IDEPREG
Rigshospitalet, Denmark
Terminated
NCT00705198 2016-11-15
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
Merck Sharp & Dohme LLC
Completed
NCT01345370 2016-01-29
ECOM
Center Eugene Marquis
Completed
NCT00751816 2015-12-10
Head & Neck Cancer Survivorship: Physical and Functional Status
Vanderbilt University
Completed
NCT00704808 2015-09-09
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Merck Sharp & Dohme LLC
Completed
NCT00725010 2015-09-09
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
Merck Sharp & Dohme LLC
Completed
NCT00178295 2015-08-05
Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury
University of Rochester
Completed
NCT00723827 2015-01-30
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Merck Sharp & Dohme LLC
Completed
NCT00897793 2013-04-12
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer
Vanderbilt-Ingram Cancer Center
Completed